Enapotamab (1912423-61-0): A Research Reagent Overview
Enapotamab, also designated as, known as 1912423-61-0, is a, the research, laboratory reagent, compound, substance gaining attention, prominence, interest within the, scientific community, field for its potential, possible, anticipated utility, application, role in biomedical, immunological, therapeutic investigations. This, It highly specific, selective antibody, protein, molecule targets, binds to, interacts with a, the particular, defined target, antigen, molecule involved, implicated, associated in disease, pathology, immune response processes, mechanisms. Currently, As of now, it, this reagent is primarily, exclusively available, offered for academic, non-commercial research, experimental purposes, applications and is not, isn't approved, sanctioned for clinical, check here diagnostic use, implementation. Further, Additional studies, investigations are necessary, required to fully, completely elucidate, determine its capabilities, functionality, scope and validate, confirm its value, utility as a, the viable, promising therapeutic, diagnostic tool, agent.
```
```text
Enapotamab: Supporting Innovative Investigation Uses
Enapotamab, a promising therapeutic molecule, is rapidly opening avenues for advanced investigation implementations. Its potential to specifically bind defined tissue types provides researchers with a versatile tool to analyze intricate molecular mechanisms. This allows exceptional understandings into disease development and advances the discovery of new diagnostic and medicinal strategies. Furthermore, researchers can now utilize enapotamab to assess previously unreachable biological locations, leading the course for revolutionary findings.
```
Research-Grade Enapota Specifications and Access
Research-grade enapotamab, previously known as Enapotamab Vedotin , is available through a limited number of specialized suppliers, primarily catering to scientific research institutions . Current specifications typically include a specified purity of ≥98%, as determined by analytical chromatography , with stringent control over related impurities. The substance weight is approximately 150 kDa, with a standard formulation consisting of a lyophilized powder to be dissolved a suitable buffer. Consecutive consistency is assured through detailed quality assurance procedures and comprehensive documentation .
- Content: ≥98%
- Molecular Weight : ~150 kDa
- State : Lyophilized Powder
```
Enapotamab Reagent (1912423-61-0) for Biological Studies
The Enapotama reagent, identified by the CAS number 1912423-61-0, is increasingly utilized in a variety of biological research. This recent antibody-based agent facilitates the analysis of specific cellular processes, often related to immune response and target protein relationships. Researchers are evaluating its potential in elucidating disease etiology and developing medicinal strategies. Further work are needed to fully characterize its features and optimize its use in various biological settings.
```
Utilizing Enapotamab regarding Leading-Edge Investigation
Investigators are increasingly focusing attention on enapotamab, a unique therapeutic, in harnessing its capabilities via groundbreaking investigation. This effort offers the prospect to deepen our understanding of intricate biological functions and possibly discover new treatment approaches in several conditions. Additional exploration regarding enapotamab's process of effect suggests a important impact on the horizon of medical study.
Enapotamab (1912423-61-0): A Provider for Premium Reagent Details
Seeking reliable availability to Enapotamab (1912423-61-0)? We offer the superior chemical solution designed for scientific purposes. Our Enapotamab is manufactured with stringent quality measures, guaranteeing optimal results in your studies. We understand the important role that high-quality compounds serve in scientific investigations.
- Purity guaranteed to specified levels.
- Thorough reports of testing provided.
- Secure storage to material quality.
Contact our team to discover additional about this Enapotamab compound also how can benefit scientific research.